ANRO

COM:ALTONEUROSCIENCE

Alto Neuroscience

  • Stock

Last Close

4.27

21/11 15:00

Market Cap

338.20M

Beta: -

Volume Today

134.93K

Avg: -

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company that engages in the psychiatry drug development business. The company develops ALTO-100 for the treatment of patients with major depressive disorder (MDD) and post-traumatic stress disorder; ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties to ...Show More

peer of

invested in

investor of